Protocol for a population-based study of rheumatic heart disease prevalence and cardiovascular outcomes among schoolchildren in Nepal

Thomas Pilgrim, Bindu Kalesan, Prahlad Karki, Anil Basnet, Bernhard Meier, Philip Urban, Nikesh Raj Shrestha, Thomas Pilgrim, Bindu Kalesan, Prahlad Karki, Anil Basnet, Bernhard Meier, Philip Urban, Nikesh Raj Shrestha

Abstract

Introduction: Rheumatic heart disease (RHD) remains a major contributor to morbidity and mortality in developing countries. The reported prevalence rates of RHD are highly variable and mainly attributable to differences in the sensitivity of either clinical screening to detect advanced heart disease or echocardiographic evaluation where disease is diagnosed earlier across a continuous spectrum. The clinical significance of diagnosis of subclinical RHD by echocardiographic screening and early implementation of secondary prevention has not been clearly established.

Methods and analysis: The authors designed a cross-sectional survey to determine the prevalence of RHD in children from private and public schools between the age of 5 and 15 years in urban and rural areas of Eastern Nepal using both cardiac auscultation and echocardiographic evaluation. Children with RHD will be treated with secondary prevention and enrolled in a prospective cohort study. The authors will compare the prevalence rates by cardiac auscultation and echocardiography, determine risk factors associated with diagnosis and progression of RHD, investigate social and economic barriers for receiving adequate cardiac care and assess clinical outcomes with regular medical surveillance as a function of stage of disease at the time of diagnosis. Prospective clinical studies investigating the impact of secondary prevention for subclinical RHD on long-term clinical outcome will be of central relevance for future health resource utilisation in developing countries.

Ethics and dissemination: The study was considered ethically uncritical and was given an exempt status by the ethics committee at University of Bern, Switzerland. The study has been submitted to the National Nepal Health Research Council and was registered with http://www.ClinicalTrials.gov (NCT01550068). The study findings will be reported in peer-reviewed publications. CLINICALTRIALS.GOV IDENTIFIER: NCT01550068.

Conflict of interest statement

Competing interests: None.

References

    1. Carapetis JR, Currie BJ, Mathews JD. Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol Infect 2000;124:239–44
    1. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005;366:155–68
    1. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011;3:67–87
    1. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:470–6
    1. Bhaya M, Panwar S, Beniwal R, et al. High prevalence of rheumatic heart disease detected by echocardiography in school children. Echocardiography 2009;27:448–53
    1. Saxena A, Ramakrishnan S, Roy A, et al. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilization and Monitoring Actuarial Trends in Indian Children) study. Heart 2011;97:2018–22
    1. Sadiq M, Islam K, Abid R, et al. Prevalence of rheumatic heart disease in school children in urban Lahore. Heart 2009;95:353–7
    1. Bahadur KC, Sharma D, Shrestha MP, et al. Prevalence of rheumatic and congenital heart disease in schoolchildren of Kathmandu valley in Nepal. Indian Heart J 2003;5:615–18
    1. Jose VJ, Gomathi M. Declining prevalence of rheumatic heart disease in rural schoolchildren in India: 2001–2002. Indian Heart J 2003;55:158–60
    1. Ahmed J, Mostafa Zaman M, Monzur Hassan MM. Prevalence of rheumatic fever and rheumatic heart disease in rural Bangladesh. Trop Doct 2005;35:160–1
    1. Periwal KL, Gupta BK, Panwar RB, et al. Prevalence of rheumatic heart disease in school children in Bikaner: an echocardiographic study. J Assoc Physicians India 2006;54:279–82
    1. Carapetis J, Parr J, Cherian T. Standardization of Epidemiologic Protocols for Surveillance of Post-Streptococcal Sequelae: Acute Rheumatic Fever, Rheumatic Heart Disease and Acute Post-Streptococcal Glomerulonephritis. Department of Health and Human Services, National Institutes of Health, 2010.
    1. Remenyi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline. Nat Rev Cardiol 2012;9:297–309
    1. Pelajo CF, Lopez-Benitez JM, Torres JM, et al. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr Rheumatol Online J 2010;8:22.
    1. UNICEF Statistics 2005–2010. (accessed 16 Apr 2012).
    1. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis of acute streptococcal pharyngitis. A scientific statement from the American Association of Rheumatic fever, Endocarditis, and Kawasaki Disease Committee of the Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009;119:1541–51
    1. . Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992;268:2069–73
    1. Uzark K, Jones K, Slusher J, et al. Quality of life in children with heart disease as perceived by children and parents. Pediatrics 2008;121:e1060–7
    1. Bennett S, Woods T, Liyanage WM, et al. A simplified general method for cluster-sample survey of health in developing countries. World Health Stat Q 1991;44:98–106

Source: PubMed

3
Se inscrever